The transcription factor nuclear factor-κB (NF-κB) family has a central regulatory role in the expression of many genes related to immune responses, inflammation, cell survival and cancer. Previous evidence demonstrated causal links between a dysregulated noncanonical NF-κB signaling and several cancer types and autoimmune diseases, yet specific inhibitors targeting this pathway remain scarce.